These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12923579)

  • 1. Life threatening bleeding under adequate oral anticoagulation. Cases 4a, b.
    Aegerter Ch; Fontana S; Fux Ch; Demarmels Biasiutti F
    Hamostaseologie; 2003 Aug; 23(3):113-6. PubMed ID: 12923579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An uncommon cause of severe soft tissue bleeding during phenprocoumon treatment].
    Neuhaus T; Hertfelder HJ; Hess L; Oldenburg J; Walger P; Vetter H
    Dtsch Med Wochenschr; 2001 Jun; 126(25-26):754-6. PubMed ID: 11455667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy.
    Mülling N; Rosery V; Reinhardt HC; Hanoun M
    Eur J Med Res; 2021 Jun; 26(1):63. PubMed ID: 34187575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical problems with oral anticoagulation -- 3 case reports].
    Lämmle B
    Ther Umsch; 2003 Jan; 60(1):63-6. PubMed ID: 12638482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Derailed oral anticoagulation with very high INR values and poor response to oral vitamin K--cholestasis as a possible cause].
    Fontana S; Zeerleder S; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):477-80. PubMed ID: 10517112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe bleeding in two patients due to increased sensitivity of factor IX activity to phenprocoumon therapy.
    Quenzel EM; Hertfelder HJ; Oldenburg J
    Ann Hematol; 1997 Jun; 74(6):265-8. PubMed ID: 9236510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No impact of factor IX Ala-10 mutations in acenocoumarol-treated southern Europeans.
    Tàssies D; Monteagudo J; Maragall S; Ordinas A; Reverter JC
    Blood Coagul Fibrinolysis; 2005 Nov; 16(8):563-6. PubMed ID: 16269929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sensitivity of factor IX to phenprocoumon as a cause of bleeding in a patient with antiphospholipid antibody associated thrombosis.
    Harbrecht U; Oldenburg J; Klein P; Weber D; Rockstroh J; Hanfland P
    J Intern Med; 1998 Jan; 243(1):73-7. PubMed ID: 9487334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The overdosed patient and bleedings with oral anticoagulation.
    Pindur G; Mörsdorf S; Schenk JF; Krischek B; Heinrich W; Wenzel E
    Semin Thromb Hemost; 1999; 25(1):85-8. PubMed ID: 10327226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No indication for APTT screening in patients on oral anticoagulant therapy.
    van der Meer FJ; Vos HL; Rosendaal FR
    Thromb Haemost; 1999 Mar; 81(3):364-6. PubMed ID: 10102461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Conundrum of "Warfarin Hypersensitivity": Prolonged Partial Thromboplastin Time From Factor IX Propeptide Mutation.
    Sekhri A; Lisinschi A; Furqan M; Palaniswamy C; Mukhi N; Gupta R; Nelson JC
    Am J Ther; 2016; 23(3):e911-5. PubMed ID: 24832385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital hypersensitivity to vitamin K antagonists due to FIX propeptide mutation at locus -10: a (not so) rare cause of bleeding under oral anticoagulant therapy in Switzerland.
    Ulrich S; Brand B; Speich R; Oldenburg J; Asmis L
    Swiss Med Wkly; 2008 Feb; 138(7-8):100-7. PubMed ID: 18293119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of molecular markers for administration of anticoagulant therapy after heart valve replacement].
    Dahm M; Lotz J; Hafner G; Oelert H; Prellwitz W
    Z Kardiol; 1998; 87 Suppl 4():42-5. PubMed ID: 9857466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study.
    Lorenz R; Kienast J; Otto U; Kiehl M; Schreiter D; Haertel S; Barthels M
    Blood Coagul Fibrinolysis; 2007 Sep; 18(6):565-70. PubMed ID: 17762533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation.
    Bertram M; Bonsanto M; Hacke W; Schwab S
    J Neurol; 2000 Mar; 247(3):209-14. PubMed ID: 10787117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reversal of oral anticoagulation in intracranial hemorrhage].
    Bösel J; Steiner T
    Dtsch Med Wochenschr; 2010 Nov; 135(47):2366-9. PubMed ID: 21082529
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anticoagulation in patients with heart valve replacement in pregnancy].
    Harenberg J
    Z Kardiol; 1998; 87 Suppl 4():63-7. PubMed ID: 9857469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phenprocoumon-induced necrotizing hepatitis].
    Schneider AR; Hartmann D; Arnold JC; Bohrer MH; Riemann JF
    Dtsch Med Wochenschr; 2001 Apr; 126(16):457-9. PubMed ID: 11360450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.